US launches Germany pharma pricing probe, raising threat of new tariffs

AI justification

Trade probe risks harming healthcare access and escalating tensions; outweighs speculative benefits. | The US trade probe into Germany's pharmaceutical pricing policies has mixed ethical implications. While it may address concerns about fair compensation for innovative medicines, the probe risks escalating trade tensions and imposing tariffs that could harm economic relations and reduce access to affordable healthcare. The potential for harm to consumer welfare and sovereign policy-making outwei